Nucleic Acids Encoding Mosaic Hiv-1 Gag Proteins

Abstract

The disclosure generally relates to an immunogenic composition (e.g., a vaccine) and, in particular, to a polyvalent immunogenic composition, such as a polyvalent HIV vaccine, and to methods of using same.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 15, 2016
  • Application: Apr 17, 2015
    US US 201514689957 A
  • Priority: Apr 17, 2015
    US US 201514689957 A
  • Priority: Feb 17, 2012
    US US 201213399963 A
  • Priority: Apr 20, 2009
    US US 99022209 A
  • Priority: Aug 23, 2006
    US US 2006/0032907 W
  • Priority: Nov 25, 2005
    US US 73941305 P
  • Priority: Aug 23, 2005
    US US 71015405 P

Download Citation


Sign in to the Lens

Feedback